Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Background We examined the effectiveness of molnupiravir and nirmatrelvir/ritonavir in reducing hospitalisation and deaths in a real-world cohort of non-hospitalised COVID-19 patients. Methods This was a territory-wide retrospective cohort study in Hong Kong. Non-hospitalised COVID-19 patients who attended designated outpatient clinics between 16 February and 31 March 2021 were identified.
Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
